SCHIL’s demerger from Sanofi India, sanctioned by the Mumbai bench of the National Company Law Tribunal, became effective on June 1, 2024
SCHIL’s demerger from Sanofi India, sanctioned by the Mumbai bench of the National Company Law Tribunal, became effective on June 1, 2024
Contact Details : Email id : wecare@relitrade.in | Phone No : +91 79681 99999 | Mobile No : +91 99780 60400
Links
Important Links : Fund Transfer – NEFT/RTGS | Relitrade IPO | Mandatory Information | Downloads | Contact Us | Careers | Life at Relitrade | Service Feedback | KYC Validation Link
Company : Pricing Details | Privacy Policy | Terms of Service | Refund and Cancellation | Disclaimer
Useful Links : SEBI | RBI | NSE INDIA | BSE INDIA | MCX INDIA | CDSL INDIA | NSDL | AMFI | SCORES 2.0 | SMART ODR | CDSL E-VOTING
Group Website : Relitrade IPO | Relitrade Mutual Funds | Easilywork | Policy Klub |
CIN : U67120GJ2012PTC116832 | NSE MEM NO : 14905 | BSE MEM NO : 6606 | MCX MEM NO : 46580 | CDSL :- IN-DP-CDSL-405-2019 | AMFI Reg.No: ARN-147999 | SEBI REG NO : INZ000184331
Trading and investments in Equities and Commodities are subject to market risk, there is no assurance or guarantee of the returns. Please read the Risk Disclosure Document and Do’s & Dont’s prescribed by the Exchanges carefully before investing.
Customer having any query/feedback/ clarification may for Securities Broking write to investorgrievance@relitrade.in
All Rights Reserved | © Copyright 2024 | Powered by BETANET
Use this feature to chat with our agent.